Alimera Sciences reported $10.09M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
Aerie Pharmaceuticals AERI:US $ 31.52M 4.48M
Alimera Sciences ALIM:US $ 10.09M 273K
Applied Genetic Technologies AGTC:US $ 4.32M 494K
Bayer BAYN:GR 3.94B 346M
Insmed INSM:US $ 56.75M 8.52M
Novartis NOVN:VX 3.5B 486M
Ophthotech OPHT:US $ 12.11M 4.11M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M